Epidemiology of asymptomatic pre-heart failure: a systematic review
A Bergamasco, A Luyet-Déruaz, ND Gollop… - Current Heart Failure …, 2022 - Springer
Abstract Purpose of Review To quantify the prevalence of asymptomatic pre-heart failure
(pre-HF), progression to more severe stages, and associated mortality. Recent Findings A …
(pre-HF), progression to more severe stages, and associated mortality. Recent Findings A …
Sex and race differences in N-terminal pro–B-type natriuretic peptide concentration and absolute risk of heart failure in the community
Importance Sex-and race-based differences in N-terminal pro–B-type natriuretic peptide (NT-
proBNP) concentrations are poorly understood. Clinical decisions are often informed by …
proBNP) concentrations are poorly understood. Clinical decisions are often informed by …
Die Biomarker BNP und NT‑proBNP
GM Oremek, K Passek, F Holzgreve… - Zentralblatt für …, 2023 - Springer
Die vorliegende Übersicht über die Biomarker BNP und NT-pro-BNP wird im Rahmen der
Serie „Biomarker “des Zentralblatts für Arbeitsmedizin, Arbeitsschutz und Ergonomie …
Serie „Biomarker “des Zentralblatts für Arbeitsmedizin, Arbeitsschutz und Ergonomie …
[HTML][HTML] Ethnic differences in atrial fibrillation in the United Kingdom
EK Frimodt-Møller, JJ Tang, T Biering-Sørensen… - JACC: Advances, 2024 - Elsevier
Abstract Background Within the United States, White individuals experience a higher risk of
atrial fibrillation (AF) while exhibiting a lower AF-related stroke risk compared to other ethnic …
atrial fibrillation (AF) while exhibiting a lower AF-related stroke risk compared to other ethnic …
Combining biomarkers and imaging for short‐term assessment of cardiovascular disease risk in apparently healthy adults
MO Gore, CR Ayers, A Khera, CR Defilippi… - Journal of the …, 2020 - Am Heart Assoc
Background Current strategies for cardiovascular disease (CVD) risk assessment focus on
10‐year or longer timeframes. Shorter‐term CVD risk is also clinically relevant, particularly …
10‐year or longer timeframes. Shorter‐term CVD risk is also clinically relevant, particularly …
Serum FGF21 levels predict the MACE in patients with myocardial infarction after coronary artery bypass graft surgery
W Xie, D Li, Y Shi, N Yu, Y Yan, Y Zhang… - Frontiers in …, 2022 - frontiersin.org
Objectives Prognosis evaluation in myocardial infarction (MI) patients with major adverse
clinical events (MACE) who have undergone coronary artery bypass graft (CABG) is greatly …
clinical events (MACE) who have undergone coronary artery bypass graft (CABG) is greatly …
Application of blood pre-albumin and NT-pro BNP levels in evaluating prognosis of elderly chronic heart failure patients
L Shi, Y Zhang, J Zhang, Y Gao… - Experimental and …, 2020 - spandidos-publications.com
Levels of blood pre-albumin (PA) and N-terminal pro-B-type natriuretic peptide (NT-pro
BNP) in elderly patients with chronic heart failure (CHF) and their clinical value in prognosis …
BNP) in elderly patients with chronic heart failure (CHF) and their clinical value in prognosis …
[HTML][HTML] Predictive value of NT-proBNP, procalcitonin and CVP in patients with new-onset postoperative atrial fibrillation after cardiac surgery
Z Xu, L Qian, L Zhang, Y Gao… - American Journal of …, 2022 - ncbi.nlm.nih.gov
Objective: To investigate the predictive value of N-terminal pro brain natriuretic peptide (NT-
proBNP), procalcitonin and central venous pressure (CVP) for new atrial fibrillation after …
proBNP), procalcitonin and central venous pressure (CVP) for new atrial fibrillation after …
Differences in left atrial size and function and supraventricular ectopy between Black and White participants in the ARIC study
Background Black Americans have more atrial fibrillation risk factors but lower atrial
fibrillation risk than White Americans. Left atrial (LA) enlargement and/or dysfunction …
fibrillation risk than White Americans. Left atrial (LA) enlargement and/or dysfunction …
Inpatient initiation of sacubitril/valsartan
MR Chilbert, KC Rogers, DN Ciriello… - Annals of …, 2021 - journals.sagepub.com
Objective: Discuss the literature and describe strategies to overcome barriers of inpatient
initiation of sacubitril/valsartan in patients with heart failure with reduced ejection fraction …
initiation of sacubitril/valsartan in patients with heart failure with reduced ejection fraction …